Entourage Health Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0132
- Today's High:
- $0.016
- Open Price:
- $0.0135
- 52W Low:
- $0.0101
- 52W High:
- $0.053
- Prev. Close:
- $0.011
- Volume:
- 36100
Company Statistics
- Market Cap.:
- $5.55 million
- Book Value:
- -0.349
- Revenue TTM:
- $40.30 million
- Operating Margin TTM:
- -126.69%
- Gross Profit TTM:
- $-11714922
- Profit Margin:
- 0%
- Return on Assets TTM:
- -34.1%
- Return on Equity TTM:
- -371.1%
Company Profile
Entourage Health Corp had its IPO on under the ticker symbol ETRGF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Entourage Health Corp has a staff strength of 0 employees.
Stock update
Shares of Entourage Health Corp opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.02, and closed at $0.01.
This is a +20% increase from the previous day's closing price.
A total volume of 36,100 shares were traded at the close of the day’s session.
In the last one week, shares of Entourage Health Corp have increased by +22.22%.
Entourage Health Corp's Key Ratios
Entourage Health Corp has a market cap of $5.55 million, indicating a price to book ratio of 2.5561 and a price to sales ratio of 0.1851.
In the last 12-months Entourage Health Corp’s revenue was $40.30 million with a gross profit of $-11714922 and an EBITDA of $-46664640. The EBITDA ratio measures Entourage Health Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Entourage Health Corp’s operating margin was -126.69% while its return on assets stood at -34.1% with a return of equity of -371.1%.
In Q4, Entourage Health Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 4.8%.
Entourage Health Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Entourage Health Corp’s profitability.
Entourage Health Corp stock is trading at a EV to sales ratio of 2.0995 and a EV to EBITDA ratio of -1.6716. Its price to sales ratio in the trailing 12-months stood at 0.1851.
Entourage Health Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $46.47 million
- Total Liabilities
- $141.88 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $19752
- Dividend Payout Ratio
- 0%
Entourage Health Corp ended 2024 with $46.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $46.47 million while shareholder equity stood at $-101238935.00.
Entourage Health Corp ended 2024 with $0 in deferred long-term liabilities, $141.88 million in other current liabilities, in common stock, $-319368021.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.08 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $5.15 million.
Entourage Health Corp’s total current assets stands at $40.09 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.79 million compared to accounts payable of $2.67 million and inventory worth $14.78 million.
In 2024, Entourage Health Corp's operating cash flow was $0 while its capital expenditure stood at $19752.
Comparatively, Entourage Health Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $0.053
- 52-Week Low
- $0.0101
- Analyst Target Price
- $
Entourage Health Corp stock is currently trading at $0.01 per share. It touched a 52-week high of $0.053 and a 52-week low of $0.053. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.01 and 200-day moving average was $0.02 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 2009.1% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Entourage Health Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. It offers cannabis plants, dried flower, pre-rolls, soft chews, chewing gum, cannabis oils, capsules, topicals and vapes, extracts, and edibles. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Syndicate Cannabis, Mary’s Medicinals, and Irwin Naturals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.